IN2012DN03074A - - Google Patents

Download PDF

Info

Publication number
IN2012DN03074A
IN2012DN03074A IN3074DEN2012A IN2012DN03074A IN 2012DN03074 A IN2012DN03074 A IN 2012DN03074A IN 3074DEN2012 A IN3074DEN2012 A IN 3074DEN2012A IN 2012DN03074 A IN2012DN03074 A IN 2012DN03074A
Authority
IN
India
Prior art keywords
analogs
disease
treatment
well
pharmacokinetic properties
Prior art date
Application number
Other languages
English (en)
Inventor
Kazimierz A Wisniewski
Claudio Daniel Schteingart
Sudarkodi Alagarsamy
Guangcheng Jian
Pierre Riviere
Javier Sueiras-Diaz
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP09173900A external-priority patent/EP2314616A1/en
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of IN2012DN03074A publication Critical patent/IN2012DN03074A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IN3074DEN2012 2009-10-23 2010-10-21 IN2012DN03074A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25449009P 2009-10-23 2009-10-23
EP09173900A EP2314616A1 (en) 2009-10-23 2009-10-23 Peptidic GLP-2 agonists
PCT/US2010/053570 WO2011050174A1 (en) 2009-10-23 2010-10-21 Peptidic glp-2 agonists

Publications (1)

Publication Number Publication Date
IN2012DN03074A true IN2012DN03074A (pt) 2015-07-31

Family

ID=53052624

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3074DEN2012 IN2012DN03074A (pt) 2009-10-23 2010-10-21

Country Status (5)

Country Link
HK (1) HK1173659A1 (pt)
HR (1) HRP20150211T1 (pt)
IN (1) IN2012DN03074A (pt)
SA (1) SA110310791B1 (pt)
SM (1) SMT201500065B (pt)

Also Published As

Publication number Publication date
SMT201500065B (it) 2015-05-05
HK1173659A1 (en) 2013-05-24
SA110310791B1 (ar) 2014-06-04
HRP20150211T1 (hr) 2015-06-05

Similar Documents

Publication Publication Date Title
JO3026B1 (ar) مستضادات ببتيد شبيه الجلوكاجون - 2
IN2012DN02737A (pt)
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
EA201170465A1 (ru) Способы лечения прогрессирующего множественного склероза
TN2012000161A1 (en) Spiro-oxindole mdm2 antagonists
MX2011007930A (es) Conjugados de insulina cristalina.
IT1395519B1 (it) Pezzo composito, nonche' impiego del pezzo composito
UA102432C2 (ru) Цитотоксичные конъюгаты с соединением, которое связывает рецептор нейропептиду y
AP2014007399A0 (en) Phenyl-3-AZA-bicycloÄ3.1.0Ühex-3-YL-methanones andthe use thereof as medicament
CL2011001427A1 (es) Compuestos derivados de 4-azetidinil-1-heteroaril-ciclohexanol; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como epoc, aterosclerosis, artritis reumatoide, entre otras.
IN2014DN06104A (pt)
MX357656B (es) Alfa-1-microglobulina para usarse en tratamiento de enfermedades relacionadas a mitocondrias.
GB201010958D0 (en) Process for manufacturing perfluoroolefins by pyrolysis of perfluorocarbons in the presence of hydrogen
IN2012DN03074A (pt)
MX2012004727A (es) Agonistas peptidicos del glp-2.
NZ609924A (en) Porphyrin treatment of neurodegenerative diseases
UA44395U (ru) Применение тиоцетама в качестве диуретического средства с мягким мочегонным действием в комплексном лечении
MX2012012509A (es) Tapentadol para usarse en el tratamiento del sindrome del intestino irritable.
TH93145B (th) เครื่องคิดเลขไฟฟ้า
UA41660U (en) Use of jacton and mexidol as actoprotector
UA92646C2 (ru) применение производных 2-оксоиндолин-3-глиоксиловой кислоты в качестве средств с актопротекторным действием
HU0900258D0 (en) The treatment of brain tumours by pyrithiamine
CY1116095T1 (el) Πεπτιδικοι αγωνιστες gla-2
TH106932B (th) ม้านั่ง
AU324936S (en) Channel section